Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM

BACKGROUND: Better biomarkers must be found to develop clinically useful urine tests for bladder cancer. Proteomics can be used to identify the proteins released by cancer cell lines and generate candidate markers for developing such tests. METHODS: We used shotgun proteomics to identify proteins re...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Br J Cancer
Prif Awduron: Bryan, R T, Regan, H L, Pirrie, S J, Devall, A J, Cheng, K K, Zeegers, M P, James, N D, Knowles, M A, Ward, D G
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Nature Publishing Group 2015
Pynciau:
Molecular Diagnostics
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4366887/
https://ncbi.nlm.nih.gov/pubmed/25719831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.21
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg